None listed
Conditions
Interventions
Intervention1: Face cleanser: Cleanser (Liq-95-35): PRODUCT A
Control Intervention1: N/AP: Not Applicable
Sponsors
ITC Limited
Eligibility
Inclusion criteria
Inclusion criteria: Standard criteria 1.Indian Female subjects 2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 3.Between 18 and 40 years of age. 4.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.) Specific criteria 1.Subjects representing varied skin types (ideally equal representation of all 5 skin types ââ?¬â?? Oily, Normal, Dry, Combination & Sensitive [Sensitive skin type : As per the Baumannââ?¬•s questionnaire answered by subjects, please refere appendix 7]) 2.Subjects representing varied eye conditions (ideally equal representation of Normal Condition and Contact Lens Users). 3.Having a habit of applying make up and waterproof make up.
Exclusion criteria
Exclusion criteria: Exclusion Criteria Standard criteria 1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2.Having refused to give her assent by not signing the consent form 3.Taking part in another study liable to interfere with this study 4.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 5.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex 6.Having a progressive asthma (either under treatment or last fit in the last 2 years) 7.Being epileptic 8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 10.Having cutaneous hypersensitivity. 11.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 13.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit 14.Having applied a cosmetic product (included make-up) on the studied areas the first day of the study. 15.Refusing to follow the study restrictions 16.Specific criteria 17.Having ocular problems (stye, chalazion, conjunctivitis). 18.Having known history or present condition of allergic response to any cosmetic products (eye/ facial cosmetic products). 19.Having eye infection or allergy. 20.Having extremely sensitive eye condition. 21.Having any form cutaneous disease which may influence the study result.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ophthalmological and Dermatological safety of the test product in causing no ocular or dermal irritation on repeated use.Timepoint: T0,T1 day,T2 day,T3 days,T4 days, T6 days,T9 days,T13 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post use skin sensorials and product efficacy in skin cleansing and removal of color cosmetics.Timepoint: T0,T1 day,T2 day,T3 days,T4 days, T6 days,T9 days,T13 days. | — |
Countries
India
Contacts
Public ContactMr Mohit Lalvani
Mascot-Spincontrol India Pvt. Ltd.
Outcome results
None listed